Vice President API Manufacturing, Bachem
CMC Development Concept for Synthetic Peptides
Bachem’s modular concept for CMC development is based on experience with a wide range of customers. The concept covers the complete API life cycle and will be discussed with emphasis on milestones and deliverables commensurate to the clinical development phases.
After obtaining his PhD in organic and physical chemistry Daniel joined Bachem's peptide manufacturing headquarters in Switzerland in 2007. As a team leader he has been responsible for the synthesis of peptides and small proteins. From 2009 to 2011 he held a lab head position focusing on process optimization, technology transfer and scale-up of synthetic peptide manufacturing procedures. In 2010 Daniel joined Bachem in the United Kingdom temporarily focusing on non-GMP custom syntheses of peptides. From the beginning of 2012 he has been leading Bachem’s cGMP API manufacturing groups back in Switzerland applying large scale SPPS and preparative HPLC. He is currently a Vice President API Manufacturing and has full responsibility for all solid-phase peptide manufacturing aspects within Bachem AG.